Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.

Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in ...

Falsely claiming to be a nurse without registration with the Nursing and Midwifery Council is to become a criminal offence, ...

CoV-2’s origin continue to circulate, further complicating efforts to maintain a constructive, evidence-based public ...

Research found no significant increase in the incidence of new thyroid cancer cases among patients treated with RAIT for ...

Remission rates in rheumatoid arthritis vary on the basis of the region in England and Wales, with patients with longer ...

As AI grows more ubiquitous in medicine, it’s showing up in the world of cardiovascular disease prediction too.

Continuing aspirin use perioperatively during subdural hematoma surgery neither increases recurrence risk nor reduces ...

One study, presented here at the annual meeting of the Society for Investigative Dermatology (SID), reported a 965% increase ...

Prophylactic trimethoprim-sulfamethoxazole lowered serious infection risk in patients with ANCA-associated vasculitis, ...

Psychotherapy use in the United States increased and psychotropic drug use declined from 2018 to 2021, with fewer patients ...

Short-term results from a recent trial suggest that reduced-dose chemoradiotherapy may achieve high local control with less ...